Yufeng Lv - Search Results

Year	Number of Results
2014	2
2016	4
2017	1
2018	5
2019	9
2020	3
2021	2
2022	1

1

Expression and gene regulation network of RBM8A in hepatocellular carcinoma based on data mining.

Lin Y, Liang R, Qiu Y, Lv Y, Zhang J, Qin G, Yuan C, Liu Z, Li Y, Zou D, Mao Y. Lin Y, et al. Among authors: lv y. Aging (Albany NY). 2019 Jan 22;11(2):423-447. doi: 10.18632/aging.101749. Aging (Albany NY). 2019. PMID: 30670676 Free PMC article.

2

A Five-microRNA Signature as Risk Stratification System in Uterine Corpus Endometrial Carcinoma.

Chen Z, Huang X, Lv Y, Fang Y, Pan L, Gan Z, Huang Z, Wei W. Chen Z, et al. Among authors: lv y. Comb Chem High Throughput Screen. 2021;24(2):187-194. doi: 10.2174/1386207323999200730211227. Comb Chem High Throughput Screen. 2021. PMID: 32748742

3

Four-miRNA signature as a prognostic tool for lung adenocarcinoma.

Lin Y, Lv Y, Liang R, Yuan C, Zhang J, He D, Zheng X, Zhang J. Lin Y, et al. Among authors: lv y. Onco Targets Ther. 2017 Dec 21;11:29-36. doi: 10.2147/OTT.S155016. eCollection 2018. Onco Targets Ther. 2017. PMID: 29317831 Free PMC article.

4

Prognostic value of CXCL17 and CXCR8 expression in patients with colon cancer.

Yao H, Lv Y, Bai X, Yu Z, Liu X. Yao H, et al. Among authors: lv y. Oncol Lett. 2020 Sep;20(3):2711-2720. doi: 10.3892/ol.2020.11819. Epub 2020 Jul 7. Oncol Lett. 2020. PMID: 32782587 Free PMC article.

5

Identification and Validation of a Malignant Cell Subset Marker-Based Polygenic Risk Score in Stomach Adenocarcinoma Through Integrated Analysis of Bulk and Single-Cell RNA Sequencing Data.

Zou Q, Lv Y, Gan Z, Liao S, Liang Z. Zou Q, et al. Among authors: lv y. Front Cell Dev Biol. 2021 Oct 18;9:720649. doi: 10.3389/fcell.2021.720649. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34733840 Free PMC article.

6

Identification of the association between HMMR expression and progression of hepatocellular carcinoma via construction of a co-expression network.

Lu D, Bai X, Zou Q, Gan Z, Lv Y. Lu D, et al. Among authors: lv y. Oncol Lett. 2020 Sep;20(3):2645-2654. doi: 10.3892/ol.2020.11844. Epub 2020 Jul 9. Oncol Lett. 2020. PMID: 32765791 Free PMC article.

7

MiRNA expression patterns are associated with tumor mutational burden in lung adenocarcinoma.

Lv Y, Huang Z, Lin Y, Fang Y, Chen Z, Pan L, Zhang Y, Xu Z. Lv Y, et al. Oncoimmunology. 2019 Jun 24;8(10):e1629260. doi: 10.1080/2162402X.2019.1629260. eCollection 2019. Oncoimmunology. 2019. PMID: 31646073 Free PMC article.

8

Enhance the treatment of low strength wastewater at low temperature with the coexistence system of AnAOB and heterotrophic bacteria: Performance and bacterial community.

Lv Y, Pan J, Huo T, Li J, Liu S. Lv Y, et al. Sci Total Environ. 2020 Apr 20;714:136799. doi: 10.1016/j.scitotenv.2020.136799. Epub 2020 Jan 18. Sci Total Environ. 2020. PMID: 31982768

9

Identification of key genes involved in the metastasis of clear cell renal cell carcinoma.

Wei W, Lv Y, Gan Z, Zhang Y, Han X, Xu Z. Wei W, et al. Among authors: lv y. Oncol Lett. 2019 May;17(5):4321-4328. doi: 10.3892/ol.2019.10130. Epub 2019 Mar 8. Oncol Lett. 2019. PMID: 30988807 Free PMC article.

10

Construction and validation of a seven-microRNA signature as a prognostic tool for lung squamous cell carcinoma.

Gan Z, Zou Q, Lin Y, Huang X, Huang Z, Chen Z, Xu Z, Lv Y. Gan Z, et al. Among authors: lv y. Cancer Manag Res. 2019 Jun 21;11:5701-5709. doi: 10.2147/CMAR.S191637. eCollection 2019. Cancer Manag Res. 2019. PMID: 31417313 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results